COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …

Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2.
Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem …

Resumen El Coronavirus SARS-CoV-2 produce la enfermedad COVID-19, cuya
manifestación más grave y potencialmente letal es la neumonía. En este artículo …

Despite thromboprophylaxis, patients with coronavirus disease 2019 (COVID‐19) exhibit
hypercoagulability and higher venous thromboembolic risk, although its real incidence is still …

There is increasing evidence that novel coronavirus disease 2019 (COVID-19) leads to a
significant coagulopathy, a phenomenon termed “COVID-19 associated coagulopathy.” …

Background: Emerging evidence shows that coronavirus disease 2019 (COVID-19) is
commonly complicated by coagulopathy, and venous thromboembolism (VTE) is considered …

Background SARS-CoV-2 is a severe respiratory infection that infects humans. Its outburst
entitled it as a pandemic emergence. To get a grip on this outbreak, specific preventive and …

Cytokines in cardiac tissue plays a key role in progression of cardiometabolic diseases and
cardiotoxicity induced by several anticancer drugs. Interleukin-1β is one on the most studied …

Many viral infections cause oral manifestations, including disorders in odontogenesis,
resulting in dental malformations. In this review, based on current knowledge, we will …

Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
December 2019, the virus's dynamicity has resulted in the evolution of various variants …